Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21479606 | 0.74 | CTSK (0.37) | CES2CES1HDAC8HDAC6CTSK | |
| SCHEMBL1288230 | 0.74 | CES2 (0.41) | CES2CES1HDAC8HDAC6CTSK | |
| SCHEMBL9876587 | 0.74 | CES2 (0.41) | CES2CES1HDAC8HDAC6CTSK | |
| SCHEMBL2352505 | 0.74 | CES2 (0.41) | CES2CES1HDAC8HDAC6CTSK | |
| SCHEMBL27342330 | 0.72 | CES2 (0.39) | CES2CES1HDAC8HDAC6CTSK | |
| SCHEMBL11789278 | 0.71 | — | — | |
| SCHEMBL3019233 | 0.70 | CES2 (0.38) | CES2CES1HDAC8HDAC6CTSK | |
| SCHEMBL3019236 | 0.70 | CES2 (0.38) | CES2CES1HDAC8HDAC6CTSK | |
| SCHEMBL9656002 | 0.68 | CES2 (0.36) | CES2CES1HDAC8HDAC6CTSK | |
| SCHEMBL4857238 | 0.67 | CES2 (0.35) | CES2CES1HDAC8HDAC6CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200331938-A1 | METHODS AND DEVICES FOR ULTRASENSITIVE DIRECT DETECTION OF MICROORGANISMS | HELIXBIND, INC. (US) | 2020-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200331938-A1 | METHODS AND DEVICES FOR ULTRASENSITIVE DIRECT DETECTION OF MICROORGANISMS | DNTT, CGAS, DDX5 | CES2 2519/4885CES1 3304/4885HDAC8 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.